Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Yip

Showing results (321-330 of 343) with videos related to

Pageof 35
Sort By:
Clinical Biochemistry|October 8, 2020
Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serologyDana Bailey, Danijela Konforte, Vilte E Barakauskas, et al.
Cancer|March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancerDaniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Breast Cancer : Basic and Clinical Research|December 4, 2025
Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World SettingKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Advances in Therapy|March 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS StudyKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 29, 2024
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancerGeoffrey T Gotto, Steven M Yip, Bobby Shayegan, et al.
Cancer|October 12, 2018
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumSteven M Yip, Connor Wells, Raphael Moreira, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2018
Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid TreatmentJiayun Shen, James F Griffith, Tracy Y Zhu, et al.
Clinical Chemistry and Laboratory Medicine|April 12, 2023
Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest GroupsJulie L V Shaw, Saranya Arnoldo, Lori Beach, et al.
NPJ Digital Medicine|April 17, 2026
Development and validation of a novel blood-based biomarker for gastric cancer triage in chronic dyspepsiaMinji Seo, Ka Man Cheung, Serene J L Lam, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)Steven M Yip, Jose M Ruiz Morales, Frede Donskov, et al.
Pageof 35

Showing results (321-330 of 343) with videos related to

Sort By:
Pageof 35
Clinical Biochemistry|October 8, 2020
Canadian society of clinical chemists (CSCC) interim consensus guidance for testing and reporting of SARS-CoV-2 serologyDana Bailey, Danijela Konforte, Vilte E Barakauskas, et al.
Cancer|March 10, 2021
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancerDaniel H Kwon, Jonathan Chou, Steven M Yip, et al.
Breast Cancer : Basic and Clinical Research|December 4, 2025
Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World SettingKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Advances in Therapy|March 10, 2026
Treatment Patterns and Clinical Outcomes in Metastatic HR+/HER2- and Triple-Negative Breast Cancer in Canada: The HER2- TRENDS StudyKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 29, 2024
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancerGeoffrey T Gotto, Steven M Yip, Bobby Shayegan, et al.
Cancer|October 12, 2018
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumSteven M Yip, Connor Wells, Raphael Moreira, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2018
Bone Mass, Microstructure, and Strength Can Discriminate Vertebral Fracture in Patients on Long-Term Steroid TreatmentJiayun Shen, James F Griffith, Tracy Y Zhu, et al.
Clinical Chemistry and Laboratory Medicine|April 12, 2023
Establishing quality indicators for point of care glucose testing: recommendations from the Canadian Society for Clinical Chemists Point of Care Testing and Quality Indicators Special Interest GroupsJulie L V Shaw, Saranya Arnoldo, Lori Beach, et al.
NPJ Digital Medicine|April 17, 2026
Development and validation of a novel blood-based biomarker for gastric cancer triage in chronic dyspepsiaMinji Seo, Ka Man Cheung, Serene J L Lam, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)Steven M Yip, Jose M Ruiz Morales, Frede Donskov, et al.
Pageof 35